Shire/New River attention drug gets conditional OK
(Re


Reuters - A new attention deficit drug made
by Shire Plc and New River Pharmaceuticals Inc. is "approvable"
by U.S. regulators for children ages 6 to 12 pending a decision
by drug enforcement authorities on the level of control it will
be subject to, the companies said on Friday.